Impact of the COVID 19 pandemic on patients suffering from musculoskeletal tumours
Background The aim of the current study was to evaluate the impact of the coronavirus disease (COVID 19) pandemic on musculoskeletal tumor service by conducting an online survey of physicians. Methods The survey was conducted among the members of the ISOLS (International Society of Limb Salvage) and the EMSOS (European Musculo Skeletal Oncology Society) The survey consisted of 20 questions (single, multiple response, ranked) origin and surgical experience of the participant (four questions) potential disruption of healthcare (12 questions) and influence of the COVID 19 pandemic on the particular physician (four questions) A matrix with four different response options was created for the particular surgical procedures) Results One hundred forty nine physicians from five continents completed the survey. Of the respondents, 20.1% and 20.7% stated that surgery for life threatening sarcomas were stopped or delayed, respectively. Even when the malignancy was expected to involve infiltration of a neurovascular bundle or fracture of a bone, still 13.8% and 14.7% of the respondents, respectively, stated that surgery was not performed. In cases of pending fractures of bone tumors, 37.5 to 46.2% of operations were canceled. Conclusion The SARS CoV 2 pandemic caused a significant reduction in healthcare (surgery, radiotherapy, chemotherapy) for malignancies of the musculoskeletal system. Delaying or stopping these treatments is life threatening or can cause severe morbidity, pain, and loss of function. Although the coronavirus disease causes severe medical complications, serious collateral damage including death due to delayed or untreated sarcomas should be avoided.
International Orthopaedics